Bright Minds Biosciences Inc. (CSE:DRUG)
108.58
+1.76 (1.65%)
Jun 3, 2026, 1:16 PM EST
Bright Minds Biosciences Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 21, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $262.36 → $303.78 | Buy | Reiterates | $262.36 → $303.78 | +179.78% | May 20, 2026 |
| Jefferies | Jefferies | Buy Initiates $200.22 | Buy | Initiates | $200.22 | +84.40% | Apr 12, 2026 |
| BTIG | BTIG | Buy Maintains $202.98 | Buy | Maintains | $202.98 | +86.94% | Mar 30, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $158.79 → $200.22 | Buy | Reiterates | $158.79 → $200.22 | +84.40% | Mar 4, 2026 |
| Robert W. Baird | Robert W. Baird | Buy Maintains $196.08 → $173.98 | Buy | Maintains | $196.08 → $173.98 | +60.24% | Feb 13, 2026 |
Unknown Analyst Chardan Capital No rating | Chardan Capital | Buy Initiates $110.47 | Buy | Initiates | $110.47 | +1.74% | Dec 31, 2025 |